Dynamic expression profile of HBsAg according to hepatic parenchyma cells' volume at different liver fibrosis stages in the immune clearance phase.
10.3760/cma.j.issn.1007-3418.2012.10.007
- VernacularTitle:慢性乙型肝炎不同肝纤维化分期的肝实质细胞体积所分摊的HBsAg表达变化
- Author:
Zhe-bin WU
1
;
Hong CAO
;
Ting LIU
;
Ze-qian WU
;
Wei-min KE
;
Zhi-liang GAO
Author Information
1. Deparment of Infectious Diseases, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
- Publication Type:Journal Article
- MeSH:
Adolescent;
Adult;
Cell Size;
Child;
Female;
Hepatitis B Surface Antigens;
blood;
Hepatitis B, Chronic;
metabolism;
pathology;
Humans;
Liver;
cytology;
metabolism;
Liver Cirrhosis;
metabolism;
pathology;
Male;
Middle Aged;
Young Adult
- From:
Chinese Journal of Hepatology
2012;20(10):742-745
- CountryChina
- Language:Chinese
-
Abstract:
The aim of this study was to determine the dynamic expression profile of hepatitis B surface antigen (HBsAg) according to hepatic parenchyma cells' volume at different stages of liver fibrosis during the immune clearance phase. Eighty-nine patients with HBeAg-positive chronic hepatitis B (CHB) in the immune clearance stage were recruited for study. Each patient's serum HBsAg levels were detected by electrochemiluminescence. The serum HBsAg levels were apportioned according to hepatic parenchyma cells' volume at liver fibrosis stages 1, 2, 3, and 4 and compared by ANOVA. The unapportioned serum HBsAg levels (IU/mL) at liver fibrosis stages 1 (227.2+/-237.7), 2 (211.0+/-131.4), 3(300.1+/-144.6), and 4 (278.7+/-148.8) were not significantly different (all comparisons, P range: 0.061 to 0.759). However, when the serum HBsAg levels were apportioned by the same hepatic parenchyma cells' volume at liver fibrosis stages 1 (343.9+/-359.8), 2 (336.4+/-209.5), 3 (508.7+/-245.1), and 4 (525.2+/-274.8), the levels were significantly different (all comparisons, F = 3.045 and P = 0.033; stage 1 vs. 3, P = 0.041; stage 1 vs. 4, P = 0.046; stage 2 vs. 3, P = 0.028; stage 2 vs. 4, P = 0.034). During the immune clearance phase of chronic hepatitis B, increased HBsAg expression is associated with increased hepatic parenchyma cells' volume and progressive liver fibrosis stage.
